Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.47 - $0.88 $15 - $29
-33 Reduced 55.0%
27 $23,000
Q3 2023

Nov 14, 2023

BUY
$0.58 - $1.41 $19 - $46
33 Added 122.22%
60 $42,000
Q2 2023

Aug 17, 2023

BUY
$0.56 - $1.2 $15 - $32
27 New
27 $30,000
Q1 2023

May 19, 2023

SELL
$0.59 - $0.86 $35 - $51
-60 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$0.61 - $8.13 $36 - $487
60 New
60 $42,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.